Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy

PURPOSE: The clinical effects of sunitinib on human myeloid-derived suppressor cell (MDSC) subsets and correlation of the T-cell–mediated immune responses and clinical outcomes in patients with oligometastases treated by stereotactic body radiotherapy (SBRT) have been evaluated. EXPERIMENTAL DESIGN:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Chen, Hui-Ming, Ma, Ge, Gildener-Leapman, Neil, Eisenstein, Samuel, Coakley, Brian A., Ozao, Junko, Mandeli, John, Divino, Celia, Schwartz, Myron, Sung, Max, Ferris, Robert, Kao, Johnny, Wang, Lu-Hai, Pan, Ping-Ying, Ko, Eric C., Chen, Shu-Hsia
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720266/
https://ncbi.nlm.nih.gov/pubmed/25922428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2742
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados